Deep vein thrombosis following hip fracture surgery

Abstract

Patients undergoing hip fracture surgery are at increased risk of deep vein thrombosis. There are limited studies of good quality assessing thromboprophylactic therapies in this patient population. Mechanical pumping devices may have a role in hip fracture patients, especially around the perioperative period, though compliance with these devices is a significant problem. Fondaparinux is the most effective pharmacological thromboprophylactic therapy following hip fracture surgery and can be used for extended prophylaxis after hospital discharge. A number of the recently published recommendations from the National Institute for Health and Clinical Excellence do not take into account the best available evidence specifically in patients undergoing hip fracture surgery, with findings from elective arthroplasty patients being extrapolated. Well-designed randomised trials are needed to determine the role of combined thromboprophylaxis, graduated compression stockings and newer oral anticoagulants so that appropriate recommendations can be made in patients undergoing hip fracture surgery.

Keywords

deep vein thrombosis hip fracture surgery thromboprophylaxis fondaparinux haemorrhagic complications NICE guidelines

Get full access to this article

View all access options for this article.

References

Amaragiri SV , Lees TA 2000. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 1: Article No. CD001484.

Borris LC 2009. Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty. Expert Opin Pharmacother 10: 1083-8.

Eriksson BI , Bauer KA , Lassen MR , et al. 2001. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 345: 1298-1304.

Eriksson BI , Dahl OE , Rosencher N. , et al. 2007. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 370: 949-56.

Eriksson BI , Lassen MR , for the Pentasacchride in Hip-Fracture Surgery Plus (PENTHIFRA Plus) Investigators. 2003. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 163: 1337-42.

Eskander MB , Limb D. , Stone MH , et al. 1997. Sequential mechanical and pharmacological thromboprophylaxis in the surgery of hip fractures. A pilot study. Int Orthop 21: 259-61.

Fisher CG , Blachut PA , Salvian AJ , et al. 1995. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis . J Orthop Trauma 9: 1-7.

Geerts WH , Bergqvist D. , Pineo GF , et al. 2008. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133: 381S-453S.

Geerts WH , Pineo GF , Heit JA , et al. 2004. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 338S-400S.

10.

Handoll HHG , Farrar MJ , McBirnie J. , et al. 2002. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 4: Article No. CD000305.

11.

Hefley WF , Nelson CL , Puskarich-May CL 1996. Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip . J Bone Joint Surg Am 78: 581-3.

12.

Hitos K. , Fletcher JP 2005. Venous thromboembolism and fractured neck of femur . Thromb Haemost 94: 991-6.

13.

Kolb G. , Bodamer I. , Galster H. , et al. 2003. Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprosthetic joint replacement or osteosynthesis of the lower limb in elderly patients. Thromb Haemost 90: 1100-5.

14.

Monreal M. , Lafoz E. , Navarro A. , et al. 1989. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. J Trauma 29: 873-5.

15.

National Collaborating Centre for Acute Care. 2009. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital NCC-AC: London.

16.

National Institute for Health and Clinical Excellence (NICE) Clinical Guideline 92. 2010. Venous thromboembolism: reducing the risk. London: NICE .

17.

Powers PJ , Gent M. , Jay RM , et al. 1989. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 149: 771-4.

18.

Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. 2000. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) Trial. Lancet 355: 1295-1302.

19.

Strebel N. , Prins M. , Agnelli G. , et al. 2002. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 162: 1451-6.

20.

Turpie AG , Bauer KA , Eriksson BI , et al. 2002. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery. Arch Intern Med 162: 1833-40.

21.

Westrich GH , Rana AJ , Terry MA , et al. 2005. Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. J Orthop Trauma 19: 234-40.

22.

Zahn HR , Skinner JA , Porteous MJ 1999. The preoperative prevalence of deep vein thrombosis in patients with femoral neck fractures and delayed operation. Injury 30: 605-7.